From: Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1
 | VEGF | TSP-1 | MVD (CD34) |
---|---|---|---|
Immunostaining score | |||
Median | 5 | 2 | 59 microvessels/mm2 |
(range) | 2–6 | 0–3 | 16–300 |
Expression intensity (% of cases) | |||
Negative | 0 | 20 | Â |
Weak | 0 | 30 | Â |
Intermediate | 17 | 30 | Â |
Strong | 83 | 20 | Â |